XML 28 R42.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value (Unobservable Inputs Reconciliation) (Details) (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Other-than-temporary impairment included in earnings $ (25) $ (200) $ (29) $ (581)
Other-than-temporary impairment (included in) transferred from other comprehensive income (25) (71) (21) (214)
Collateralized Debt Obligations | Significant Unobservable Inputs (Level 3) | Recurring
       
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Beginning balance 850 946 819 934
Other-than-temporary impairment included in earnings (25) (200) (29) (581)
Other-than-temporary impairment (included in) transferred from other comprehensive income 25 71 21 214
Other gains/losses included in other comprehensive income 5 (87) 44 163
Net swap settlement recorded 0 0 0 0
Ending balance 855 730 855 730
The amount of total gains or losses for the period included in earnings attributable to the change in unrealized gains or losses relating to assets still held at the reporting date (25) (200) (29) (581)
Collateralized Debt Obligations | IRLC and FSA | Significant Unobservable Inputs (Level 3) | Recurring
       
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
IRLC and FSA issuances 0 0 0 0
IRLC and FSA expirations and fair value changes included in earnings 0 0 0 0
IRLC transfers into closed loans/FSA transferred on sales 0 0 0 0
Mortgage Derivatives | Significant Unobservable Inputs (Level 3) | Recurring
       
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Beginning balance 272 34 (22) 218
Other-than-temporary impairment included in earnings 0 0 0 0
Other-than-temporary impairment (included in) transferred from other comprehensive income 0 0 0 0
Other gains/losses included in other comprehensive income 0 0 0 0
Net swap settlement recorded 0 0 0 0
Ending balance 361 131 361 131
The amount of total gains or losses for the period included in earnings attributable to the change in unrealized gains or losses relating to assets still held at the reporting date 0 0 0 0
Mortgage Derivatives | IRLC and FSA | Significant Unobservable Inputs (Level 3) | Recurring
       
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
IRLC and FSA issuances 767 171 862 377
IRLC and FSA expirations and fair value changes included in earnings (441) 81 (391) (146)
IRLC transfers into closed loans/FSA transferred on sales (237) (155) (88) (318)
Interest Rate Swap | Significant Unobservable Inputs (Level 3) | Recurring
       
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
Beginning balance (2,349) 103 (1,834) 817
Other-than-temporary impairment included in earnings 0 0 0 0
Other-than-temporary impairment (included in) transferred from other comprehensive income 0 0 0 0
Other gains/losses included in other comprehensive income (457) (2,001) (1,269) (2,908)
Net swap settlement recorded 153 169 450 362
Ending balance (2,653) (1,729) (2,653) (1,729)
The amount of total gains or losses for the period included in earnings attributable to the change in unrealized gains or losses relating to assets still held at the reporting date (153) (169) (450) (362)
Interest Rate Swap | IRLC and FSA | Significant Unobservable Inputs (Level 3) | Recurring
       
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]        
IRLC and FSA issuances 0 0 0 0
IRLC and FSA expirations and fair value changes included in earnings 0 0 0 0
IRLC transfers into closed loans/FSA transferred on sales $ 0 $ 0 $ 0 $ 0